GAM Holding’s Evolent Health EVH Stock Holding History

GAM Holding’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,272	Closed	-$254K	–	238
2022 Q2	$254K	Hold	8,272	–	–	0.02%	237
2022 Q1	$267K	Sell	8,272 -8,073	-49%	-$211K	0.01%	292
2021 Q4	$452K	Sell	16,345 -8,718	-35%	-$250K	0.02%	243
2021 Q3	$777K	Sell	25,063 -22,837	-48%	-$548K	0.04%	213
2021 Q2	$1.01M	Hold	47,900	–	–	0.04%	226
2021 Q1	$968K	Buy	+47,900	New	+$911K	0.05%	238
2019 Q3	–	Sell	-100,250	Closed	-$797K	–	835
2019 Q2	$797K	Hold	100,250	–	–	0.03%	556
2019 Q1	$1.26M	Buy	+100,250	New	+$1.59M	0.05%	367

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

GAM Holding's EVH Position: Q3 2022 in Review

GAM Holding sold out of Evolent Health (EVH) in Q3 2022, closing a stake of 8,272 shares — an estimated $254K sold.

GAM Holding first reported a position in EVH in Q1 2019 and held it in 8 quarters. The position peaked at $1.26M in Q1 2019. 251 funds tracked by Wall St. Rank hold EVH as of Q3 2022.

GAM Holding reported no remaining Evolent Health position as of Q3 2022 after selling out during the quarter.
GAM Holding sold 8,272 Evolent Health shares in Q3 2022, an estimated $254K.
GAM Holding first reported a position in Evolent Health in Q1 2019 and held it in 8 quarters.
GAM Holding's Evolent Health position peaked at $1.26M in Q1 2019.
251 funds tracked by Wall St. Rank held Evolent Health as of Q3 2022.

Based on GAM Holding's 13F filing for Q3 2022, filed 19 Oct 2022.